Filing Details

Accession Number:
0001192482-18-000409
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-08-22 16:39:31
Reporting Period:
2018-08-22
Accepted Time:
2018-08-22 16:39:31
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1621443 Zynerba Pharmaceuticals Inc. ZYNE () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1591467 P. John Butler C/o Zynerba Pharmaceuticals, Inc.
80 W. Lancaster Avenue, Suite 300
Devon PA 19333
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-08-22 5,000 $6.43 5,000 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $6.31 to $6.50, inclusive. The reporting person undertakes to provide Zynerba Pharmaceuticals,Inc., any security holder of Zynerba Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth infootnote 1 to this Form 4.